3.12
Xenetic Biosciences Inc stock is traded at $3.12, with a volume of 57,633.
It is down -6.59% in the last 24 hours and down -4.29% over the past month.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
See More
Previous Close:
$3.34
Open:
$3.3
24h Volume:
57,633
Relative Volume:
0.07
Market Cap:
$4.81M
Revenue:
$2.54M
Net Income/Loss:
$-4.13M
P/E Ratio:
-1.1345
EPS:
-2.75
Net Cash Flow:
$-4.11M
1W Performance:
-16.80%
1M Performance:
-4.29%
6M Performance:
+12.64%
1Y Performance:
-23.90%
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Name
Xenetic Biosciences Inc
Sector
Industry
Phone
781-778-7720
Address
945 CONCORD ST., FRAMINGHAM, MA
Compare XBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
XBIO
Xenetic Biosciences Inc
|
3.12 | 7.61M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-20 | Initiated | Maxim Group | Buy |
Xenetic Biosciences Inc Stock (XBIO) Latest News
Is Xenetic Biosciences Inc. stock bottoming outMarket Volume Report & Scalable Portfolio Growth Ideas - newser.com
What indicators show strength in Xenetic Biosciences Inc.July 2025 Spike Watch & Weekly Setup with High ROI Potential - newser.com
Using Python tools to backtest Xenetic Biosciences Inc. strategiesWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Long term hold vs stop loss in Xenetic Biosciences Inc.Weekly Profit Analysis & Smart Allocation Stock Reports - newser.com
Is Xenetic Biosciences Inc. (3XB0) stock bottoming after sell offEarnings Growth Report & Risk Managed Investment Entry Signals - newser.com
Will Xenetic Biosciences Inc. stock split attract more investorsJuly 2025 Gainers & Weekly Return Optimization Alerts - newser.com
Is Xenetic Biosciences Inc. (3XB0) stock a top pick for value investors2025 Bull vs Bear & Daily Volume Surge Signals - newser.com
Why Xenetic Biosciences Inc. is moving todayJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Is Xenetic Biosciences Inc. stock ready for breakoutMarket Performance Summary & Verified Chart Pattern Signals - newser.com
Is Xenetic Biosciences Inc. (3XB0) stock a good hedge against inflation2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
How to use Fibonacci retracement on Xenetic Biosciences Inc.Quarterly Risk Review & Weekly Momentum Stock Picks - newser.com
Will Xenetic Biosciences Inc. see short term momentumDip Buying & Risk Controlled Stock Alerts - newser.com
Detecting support and resistance levels for Xenetic Biosciences Inc.July 2025 Setups & High Accuracy Investment Signals - newser.com
Is Xenetic Biosciences Inc. (3XB0) stock suitable for passive index funds2025 Top Decliners & Daily Profit Focused Screening - newser.com
Is Xenetic Biosciences Inc. stock a good choice for value investors2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Best data tools to analyze Xenetic Biosciences Inc. stock2025 Earnings Surprises & Stepwise Trade Signal Implementation - newser.com
Is Xenetic Biosciences Inc. forming a reversal patternMarket Risk Summary & Momentum Based Trading Ideas - newser.com
Using economic indicators to assess Xenetic Biosciences Inc. potential2025 Market Trends & Low Drawdown Investment Ideas - newser.com
Can Xenetic Biosciences Inc. stock double in next 5 yearsCEO Change & Consistent Growth Equity Picks - newser.com
Xenetic Biosciences Inc. (XBIO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
XBIO 2025 proxy: 6 director elections, CBIZ auditor ratification - Stock Titan
Published on: 2025-10-31 03:41:46 - newser.com
What technical models suggest about Xenetic Biosciences Inc.’s comeback2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Xenetic Biosciences, Inc. Announces Pricing of $4.5 Million Underwritten Offering of Common Stock - Rockford Register Star
Xenetic Biosciences Inc Stock (XBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):